NEW YORK: SBI Chief Arundhati Bhattacharya, ICICI bank head Chanda Kochhar, Biocon founder Kiran Mazumdar- Shaw and HT Media Chair Shobhana Bhartia are among the world's 100 most powerful women, according to the Forbes' annual list which is topped ... Silicon India, 1 day ago
Two Indian bankers in most powerful women list - DNA India, 13 hours ago
18 entrepreneurs on Forbes list of the world's most powerful women - Business Zone, 1 day ago
7 corporate houses have offered to adopt tourist spots in state After Biocon chief Kiran Mazumdar Shaw expressed disappointment over bureaucratic hurdles to adopt the Visvesvaraya Industrial Technological Museum, the tourism department has taken up ...Bangalore Mirror, 5 days ago
Biocon, a Rs. 3,050 crore plus leading innovation-led bio-pharmaceutical company, has posted satisfactory financial performance during the fourth quarter ended March 2014. Its consolidated net profit, after exceptional income of Rs. 105 crore on ...PharmaBiz, 3 weeks ago Biocon Q4 net soars 78% at Rs 202 crore Deccan Herald, 3 weeks ago Biocon Q4 net up 78% to Rs201 crore The Financial Chronicle, 3 weeks ago Pharmaceutical Newsletter: 27-30 April, 2015 India Infoline, 4 weeks ago
Biocon top line grows 15% in Q4 FY15; Research Services delivers 27% growth; FY15 Revenues at Rs. 3143 Crore, PAT at Rs. 497 Crore
Biocon Ltd (BSE code: 532523, NSE: BIOCON), Asia's premier biopharmaceuticals company, announced its Q4 and FY 15 financial results on April 29, 2015. Commenting on the quarterly performance and highlights, Chairman and Managing Director, Kiran ...Businessworld India, 4 weeks ago Biocon's CRO Arm Syngene Seeks Approval for IPO, Files DRHP, Offer Allows Biocon to Monetize its Shareholding in Syngene Finalaya.com, 4 weeks ago BIOCON : top line grows 15% in Q4 FY15; Research Services delivers 27% growth; FY15 Revenues at Rs. 3143 Crore, PAT at Rs. 497 Crore 4 Traders, 4 weeks ago
Photo: Aniruddha Chowdhury/Mint Biocon Ltd said on Thursday that two biosimilar drug molecules developed by it to treat cancer and rheumatoid arthritis had entered global phase 3 clinical trials, which entail testing on patients to assess ...Livemint.com, 2 weeks ago
Bengaluru based bio-pharmaceutical company Biocon has announced that its consolidated net profit rose by 20.23 percent to Rs.497.43 crore for fiscal 2014-2015 compared to the profit of Rs.413.72 crore in 2013-14. The company's consolidated net ...MedIndia, 3 weeks ago Biocon's 2014-15 profit surges by 20.23 percent ProKerala.com, 4 weeks ago
More from: , SME Times...and 1 other sources
BENGALURU: The Karnataka government has come under attack from experts who say it is taking little interest to include Bengaluru in the list of 100 smart cities, an ambitious project that was approved by the Union Cabinet on Wednesday . Considered ...Economic Times, 4 weeks ago
Biocon's integrated healthcare initiatives is constantly engaged in improving the quality of life of several thousand communities in India Biocon's CSR arm Biocon Foundation has recieved WHO-India Public Health Champion Award 2015 for its ...Financial Express, 1 month ago
The government has "taken steps to create the environment for investment, which I think is important. My sense is that things are happening says RBI Governor Raghuram Rajan. Industry doyen and India's most respected business leader Narayan Murthy ...Afternoon Despatch & Courier, 3 days ago
DGAP-News: Formycon AG: Carsten Brockmeyer belongs to the top 20 most influential people in the Global 'Medici...
DGAP-News: Formycon AG / Key word(s): Miscellaneous Formycon AG: Carsten Brockmeyer belongs to the top 20 most influential people in the Global 'Medicine Maker Power List' 2015 19.05.2015 / 07:49 ...TeleTrader.com, 1 week ago
on your WebpageAdd Widget >Get your members hooked!